new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Theravance Biopharma R & d Ip Llc patents

Recent patent applications related to Theravance Biopharma R & d Ip Llc. Theravance Biopharma R & d Ip Llc is listed as an Agent/Assignee. Note: Theravance Biopharma R & d Ip Llc may have other listings under different names/spellings. We're not affiliated with Theravance Biopharma R & d Ip Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Theravance Biopharma R & d Ip Llc-related inventors




Date Theravance Biopharma R & d Ip Llc patents (updated weekly) - BOOKMARK this page
05/25/17 new patent  Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease
05/18/17Neprilysin inhibitors
05/04/17Jak kinase inhibitor compounds for treatment of respiratory disease
03/30/17(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid
03/30/17Neprilysin inhibitors
03/23/17Crystalline freebase forms of a biphenyl compound
03/23/17Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
03/09/17Neprilysin inhibitors
01/26/17Neprilysin inhibitors
01/26/17Neprilysin inhibitors
01/19/17Neprilysin inhibitors
01/12/17Neprilysin inhibitors
12/29/16Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
12/01/16Naphthyridine compounds as jak kinase inhibitors
10/06/16Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
10/06/16Combination dosage form of a mu opioid receptor antagonist and an opioid agent
08/25/16(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
08/11/16(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid
08/04/16Biphenyl compounds useful as muscarinic receptor antagonists
06/30/164-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
06/30/16Neprilysin inhibitors
06/23/168-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/16/16Crystalline forms of a biphenyl compound
05/26/16Crystalline freebase forms of a biphenyl compound
04/07/16Crystalline form of a quinolinone-carboxamide compound
03/31/16Neprilysin inhibitors
03/24/16Neprilysin inhibitors
03/17/16Neprilysin inhibitors
02/11/16Hepatitis c virus inhibitors
01/28/16Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
01/21/16Neprilysin inhibitors
01/07/16Neprilysin inhibitors
12/31/15Neprilysin inhibitors
10/15/15Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound
10/15/158-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
10/15/15Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
09/10/15Hepatitis c virus inhibitors
07/30/15Neprilysin inhibitors
07/30/15Neprilysin inhibitors
07/09/15Dual-acting imidazole antihypertensive agents
07/02/15Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
06/18/15Biphenyl compounds useful as muscarinic receptor antagonists
06/18/15Crystalline freebase forms of a biphenyl compound
06/18/15Neprilysin inhibitors
06/11/15Neprilysin inhibitors
06/04/15Crystalline forms of a biphenyl compound
05/21/15Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound
05/14/15Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
05/14/15Neprilysin inhibitors
05/07/153-phenoxymethylpyrrolidine compounds
05/07/15Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compound
04/30/15Neprilysin inhibitors
04/16/15Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents
03/19/15Crystalline form of a 3-phenoxymethylpyrrolidine compound
03/12/15Novel inhibitors of hepatitic c virus
03/12/15Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
03/05/15Dual-acting antihypertensive agents
02/19/158-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
02/05/15Process for preparing biphenyl imidazole compounds
01/08/15Dual-acting antihypertensive agents
12/11/14Neprilysin inhibitors
11/20/14Neprilysin inhibitors
11/06/14Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/14Cyclic urea derivatives as androgen receptor antagonists
10/30/14Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
Patent Packs
10/09/14Dual-acting imidazole antihypertensive agents
09/25/141-(2-phenoxymethylphenyl)piperazine compounds







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Theravance Biopharma R & d Ip Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Theravance Biopharma R & d Ip Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';